Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Recruiting 4Active not recruiting 2Terminated 1

Sponsor Class

OTHER 6NIH 1

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Endocrine 5

Conditions

Breast Neoplasms 3099Neoplasms 2443Carcinoma, Non-Small-Cell Lung 1867Prostatic Neoplasms 1619Colorectal Neoplasms 1426Lung Neoplasms 1295Multiple Myeloma 929Neoplasm Metastasis 920Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 848Ovarian Neoplasms 799Melanoma 784Carcinoma, Hepatocellular 737Stomach Neoplasms 639Brain Neoplasms 636Recurrence 633Squamous Cell Carcinoma of Head and Neck 632Head and Neck Neoplasms 609Glioblastoma 567Lymphoma 540Uterine Cervical Neoplasms 539Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 499Hematologic Neoplasms 463Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 442Lymphoma, Non-Hodgkin 436Sarcoma 434

Interventions

Cabergoline 2Tissue Banks 1Dopamine Agonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Prolactinoma × 1 year × Clear all
NCT00001595 2026-06-01

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

National Institutes of Health Clinical Center (CC)

Recruiting
2,000 enrolled
Endocrine

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

NCT03665064 2026-03-16

Long Term Outcome Study in Patients With Pituitary Disorders

University of Alberta

Active not recruiting
1,500 enrolled
Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting
70 enrolled

Hyperprolactinemia, Prolactinoma

NCT07268183 2026-01-22

OEMacroPrL

Hospices Civils de Lyon

Recruiting
180 enrolled
Endocrine

Pituitary Neoplasms, Prolactinoma

NCT06936813 2026-01-08

The PROMISE Survey

University Hospital, Basel, Switzerland

Active not recruiting
530 enrolled
Endocrine

Pituitary Neoplasms, Prolactinoma

NCT04106531 2025-12-05

Prolac-10

Ohio State University

Terminated
8 enrolled
Endocrine

Pituitary Neoplasms, Prolactinoma

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting
60 enrolled

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡